WallStreetZenWallStreetZen

NASDAQ: VTGN
Vistagen Therapeutics Inc Stock Ownership - Who owns Vistagen Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Vistagen Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Reid G. AdlerChief Legal Officer2026-06-3036,818$0.19
$7.07kBuy
Shawn SinghPresident and CEO2026-06-3036,818$0.19
$7.07kBuy
Nick B. TresslerChief Financial Officer2026-06-3011,712$0.19
$2.25kBuy
Joshua S. PrinceChief Operating Officer2025-12-314,386$0.56
$2.47kBuy

1 of 1

VTGN insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when VTGN insiders and whales buy or sell their stock.

VTGN Shareholders

What type of owners hold Vistagen Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Venrock Healthcare Capital Partners II LP50.30%20,637,286$4.89MInsider
Holding Co Cato8.07%3,310,836$784.67kInsider
Orbimed Advisors LLC7.46%3,060,000$725.22kInstitution
Tcg Crossover Management LLC6.52%2,676,580$634.35kInstitution
Vanguard Capital Management LLC3.84%1,574,200$373.09kInstitution
Platinum Long Term Growth VII LLC3.80%1,558,862$369.45kInsider
Commodore Capital LP1.95%799,244$189.42kInsider
Adar1 Capital Management LLC1.83%751,141$178.02kInstitution
Stempoint Capital LP1.50%616,749$146.17kInstitution
Acadian Asset Management LLC1.44%589,663$139.75kInstitution

1 of 3

VTGN vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
VTGN34.67%65.33%Net BuyingNet Buying
CRIS21.54%78.46%Net Buying
TRAW11.85%88.15%Net BuyingNet Buying
APRE3.63%96.37%Net Buying
CVKD3.18%35.04%Net SellingNet Selling
View Top Biotech Stocks

Vistagen Therapeutics Stock Ownership FAQ

Who owns Vistagen Therapeutics?

Vistagen Therapeutics (NASDAQ: VTGN) is owned by 35.90% institutional shareholders, 67.64% Vistagen Therapeutics insiders, and 0.00% retail investors. Venrock Healthcare Capital Partners II LP is the largest individual Vistagen Therapeutics shareholder, owning 20.64M shares representing 50.30% of the company. Venrock Healthcare Capital Partners II LP's Vistagen Therapeutics shares are currently valued at $4.85M.

If you're new to stock investing, here's how to buy Vistagen Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.